Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4383594 | 1.00 | TYR (0.45) | TYRATMPOLBSLC5A2 | |
| SCHEMBL4395822 | 0.94 | TYR (0.41) | TYRATMPOLBSLC5A2 | |
| SCHEMBL14181424 | 0.92 | TYR (0.40) | TYRATMSLC5A2 | |
| SCHEMBL14181421 | 0.92 | TYR (0.40) | TYRATMSLC5A2 | |
| SCHEMBL14181422 | 0.92 | TYR (0.40) | TYRATMSLC5A2 | |
| SCHEMBL5347798 | 0.88 | TYR (0.54) | TYR | |
| SCHEMBL5348943 | 0.88 | TYR (0.54) | TYR | |
| SCHEMBL14181423 | 0.87 | TYR (0.36) | TYRATMSLC5A2 | |
| SCHEMBL24218341 | 0.87 | TYR (0.46) | TYRATMPOLBSLC5A2 | |
| SCHEMBL22111092 | 0.87 | TYR (0.46) | TYRATMPOLBSLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7157432-B2 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | SAN-EI GEN F.F.I., INC. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-20060003946-A1 | Tissue-penetrating property, and exhibits high selectivity to tumor cells and hydrophilicity | REI MEDICAL CO., LTD. (JP) | 2006-01-05 | — | — | US | disclosed |
| EP-1316558-B9 | TETRAPHENYLBACTERIOCHLORIN DERIVATIVES AND COMPOSITIONS CONTAINING THE SAME | SAN EI GEN FFI INC (JP) | 2005-12-07 | — | — | EP | disclosed |
| US-6958389-B2 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | SAN-EI GEN F.F.I. INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| EP-1316558-B1 | TETRAPHENYLBACTERIOCHLORIN DERIVATIVES AND COMPOSITIONS CONTAINING THE SAME | SAN EI GEN FFI INC (JP) | 2005-08-17 | — | — | EP | disclosed |
| US-20030171305-A1 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | REI MEDICAL CO., LTD. (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1316558-A1 | TETRAPHENYLBACTERIOCHLORIN DERIVATIVES AND COMPOSITIONS CONTAINING THE SAME | SAN-EI GEN F.F.I., INC. (JP) | 2003-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171305-A1 | Tetraphenylbacteriochlorin derivatives and compositions containing the same | SCNN1B, SLC7A1, MGMT | TYR 3099/4885ATM 4257/4885POLB 953/4885 |
| US-20060003946-A1 | Tissue-penetrating property, and exhibits high selectivity to tumor cells and hydrophilicity | CD68, SLC7A1, SLC11A2 | TYR 2941/4885ATM 4168/4885POLB 3285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.